Key result
In patients with essential hypertension, telmisartan reduced 24-h systolic ABP by 18 mm Hg more in those with higher versus lower baseline plasma renin activity.
Why the study?
Does telmisartan reduce ambulatory blood pressure in untreated patients with essential hypertension, and does the response correlate with pretreatment plasma renin activity?
Cohort (n=11)
Does telmisartan reduce ambulatory blood pressure in untreated patients with essential hypertension, and does the response correlate with pretreatment plasma renin activity?
The blood pressure lowering effect of telmisartan in essential hypertension correlates with pretreatment plasma renin activity, suggesting PRA could predict therapeutic response.
Answers are grounded in this paper and cite their sources.
May support PRA-guided telmisartan selection in essential hypertension; hypothesis-generating pending randomized outcome trials.
BACKGROUND: Although the therapeutic response to angiotensin II receptor blockers (ARBs) is assumed impaired in patients with low-renin hypertension, data are scarce about the association between levels of plasma renin activity (PRA) before treatment and response of ambulatory blood pressure (ABP) to ARBs in essential hypertension. METHODS: We prospectively studied 11 untreated Japanese patients with essential hypertension (3 women and 8 men, mean age: 50 +/- 9 (mean +/- SD) years). After a 4-week drug-free period, telmisartan 20-40 mg was administered orally once daily for 8 weeks. PRA levels were measured before treatment. The first ABP measurement was performed at the end of the drug-free period and the second measurement at the end of the treatment period with telmisartan. RESULTS: Telmisartan significantly decreased the 24-h ABP by 12 +/- 11 mm Hg systolic (P < 0.01) and 9 +/- 8 mm Hg diastolic (P < 0.01). Reductions in the 24-h systolic and diastolic ABPs were significantly greater in five patients with higher renin levels (> or =0.65 ng/ml/h) than in six patients with lower renin levels (<0.65 ng/ml/h) by 18 mm Hg systolic (P < 0.001) and 11 mm Hg diastolic (P < 0.05). Changes in the 24-h systolic and diastolic ABPs significantly correlated with log PRA before treatment. CONCLUSIONS: The ABP lowering effects of telmisartan were dependent on PRA levels before treatment in patients with essential hypertension. Measurement of PRA levels before treatment is thought to be useful for prediction of the ABP lowering effects of telmisartan.
No takes yet. Share an insight, caveat, or question.
Minami et al. (2007) conducted a cohort in Essential hypertension (n=11). Telmisartan vs. Lower baseline plasma renin activity (<0.65 ng/ml/h) was evaluated on Change in 24-h ambulatory blood pressure (ABP) (MD 18 mm Hg systolic, p=<0.001). In patients with essential hypertension, telmisartan reduced 24-h systolic ABP by 18 mm Hg more in those with higher versus lower baseline plasma renin activity.
Synapse has enriched 10 related papers. Consider them for comparative context: